Promote Your Research… Share it Worldwide
Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global NewsThe Landmark GLOBOCAN 2018 Report: A Comprehensive Snapshot of Global Cancer Burden
In 2018, the International Agency for Research on Cancer released its highly anticipated GLOBOCAN estimates, painting a detailed picture of cancer incidence and mortality across 185 countries and 36 cancer types. This report, led by researchers including F. Bray, J. Ferlay, and I. Soerjomataram, remains a cornerstone for understanding worldwide cancer trends and guiding public health strategies. It highlights how cancer continues to rank among the top causes of premature death globally, with significant variations driven by economic development, lifestyle factors, and access to care.
Understanding the Scale: Key Numbers from the 2018 Estimates
The report estimates 18.1 million new cancer cases and 9.6 million deaths worldwide in 2018. Excluding non-melanoma skin cancers, these figures stand at 17.0 million cases and 9.5 million deaths. Asia bore nearly half of all cases and over half of deaths, reflecting its large population share, while Europe and the Americas accounted for substantial portions despite smaller populations. These numbers underscore the urgent need for targeted interventions, especially in transitioning economies where case fatality rates remain higher.
Top Cancers Driving the Global Burden
Lung cancer emerged as the most commonly diagnosed cancer overall at 11.6 percent of cases and the leading cause of death at 18.4 percent. Breast cancer followed closely in incidence for women, while colorectal, stomach, and liver cancers featured prominently in mortality rankings. Prostate cancer ranked high among men. The top ten cancer types collectively explained over 65 percent of new diagnoses and deaths, highlighting opportunities for prevention through known risk factors like smoking, diet, and infections.
| Cancer Type | Incidence Share | Mortality Share |
|---|---|---|
| Lung | 11.6% | 18.4% |
| Breast (female) | 11.6% | 6.6% |
| Colorectal | 10.2% | 9.2% |
| Prostate | 7.1% | 3.8% |
| Stomach | 5.7% | 8.2% |
Gender Differences in Cancer Patterns
Men faced lung cancer as the top diagnosis and killer, followed by prostate and colorectal for incidence. Women saw breast cancer dominate both incidence and mortality, with colorectal, lung, and cervical cancers also significant. These patterns reflect biological, behavioral, and social influences, emphasizing the value of gender-specific screening and education programs in universities and medical training worldwide.
Photo by Martin Sanchez on Unsplash
Regional Variations and Economic Influences
Incidence and mortality shifted dramatically by region and human development level. High-income areas showed higher incidence but lower mortality due to better detection and treatment, while low- and middle-income regions faced higher death rates from late-stage diagnoses. Eastern Asia reported the highest stomach cancer burden, and lung cancer affected women increasingly in many nations. Such disparities call for strengthened global collaborations in higher education and research to build capacity where data and resources are limited.
Underlying Drivers of the Cancer Burden
Lifestyle elements such as tobacco use, unhealthy diets, physical inactivity, and alcohol consumption played major roles, alongside infections like HPV and hepatitis in certain areas. Aging populations and urbanization further amplified risks. The report stresses that many cancers are preventable, advocating for evidence-based policies that universities can help shape through public health curricula and community outreach.
Challenges in Data Collection and Registry Development
High-quality population-based cancer registries cover only a fraction of the world, limiting precise planning in many nations. The Global Initiative for Cancer Registry Development aims to close these gaps by supporting local data systems. This initiative highlights opportunities for academic institutions to contribute through training programs, collaborative studies, and technology transfer in epidemiology and biostatistics.
Implications for Higher Education and Research
The 2018 statistics serve as a vital teaching tool in medical and public health programs, illustrating real-world applications of epidemiology. Universities worldwide use such data to inspire student research projects, develop prevention curricula, and foster international partnerships. Faculty positions in cancer epidemiology and oncology remain in demand as institutions expand programs to address these global challenges.
Photo by Martin Sanchez on Unsplash
Looking Ahead: From 2018 Insights to Modern Strategies
While the 2018 figures provide a foundational benchmark, they informed subsequent efforts in early detection, vaccination programs, and personalized medicine. Continued investment in research, supported by academic networks, promises further reductions in incidence and improved survival. The report's emphasis on equity reminds us that progress depends on inclusive approaches accessible to all populations.
Actionable Steps for Stakeholders and Institutions
Individuals can reduce personal risk through lifestyle choices, while governments should prioritize registry strengthening and screening access. Universities and research centers play a pivotal role by advancing studies, training the next generation of experts, and translating findings into policy. Resources like dedicated job boards help connect talented professionals with opportunities in these critical fields.
Be the first to comment on this article!
Please keep comments respectful and on-topic.